Researchers are exploring the potential of mRNA vaccines to treat a variety of rare genetic disorders, such as hereditary tyrosinemia type 1, phenylketonuria, methylmalonic acidemia, propionic acidemia, glycogen storage disease type 1a, and ornithine transcarbamylase deficiency [22]. Here, OTC is linked to methylmalonic acidemia.